Physician profile
Stephen P Cass
NPI 1568555910
$11,477.51
in general payments reported to CMS, 2019-2025
9 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,880 · 2021: $115 · 2022: $2,734 · 2023: $616 · 2024: $4,930 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,025 · Food and Beverage: $1,664 · Consulting Fee: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,024.50 |
| Food and Beverage | $1,663.56 |
| Consulting Fee | $1,060.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $3,984.60 | 2019-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Oticon Medical, LLC | $3,087.97 | 2024 | Ponto Bone Anchored Hearing System |
| Advanced Bionics, LLC | $2,659.69 | 2019-2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Med-El Corporation | $894.89 | 2019-2024 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Zimmer Biomet Holdings, INC. | $402.65 | 2019-2024 | Htr-Pekk |
| Acclarent, INC | $238.68 | 2023-2024 | Relieva Spinplus, Trudi Nav Cable |
| Grace Medical, INC. | $122.25 | 2019 | |
| Pfizer INC. | $86.78 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Cass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.